Seattle Decriminalizes Natural Psychedelics
Seattle City Council unanimously approves a resolution declaring entheogen-related activities should be among lowest law enforcement priorities.
Seattle City Council unanimously approves a resolution declaring entheogen-related activities should be among lowest law enforcement priorities.
“We believe in the promise of the resurgence of psychedelic medicine and are proud to be collaborating with Lobe Sciences as we work together to improve the lives and health of members of the WBA family,” says WBA president Gilberto Jesús Mendoza.
This week in psychedelic business news: more evidence supporting ketamine for depression; a new use for MDMA; Lobe Sciences makes a leap in treating PTSD; Delix raises big bucks; and BetterLife Pharma patents solution for cluster headaches.
On the flip side, 37% of Oregon adults surveyed said they did not know what psilocybin was.
The Tesla and SpaceX founder, estimated to be worth nearly $200 billion, has previously hinted at using DMT.
Organizers of the largest psychedelic business event ever promise it’s not just a conference, but an experience.
“Women’s desire issues have not been adequately addressed to date, and we believe this treatment incorporating MDMA and psychotherapy has real promise,” says CEO Kelsey Ramsden
There is increasing scientific evidence that a variety of psychedelics can be used to treat a number of the risk factors linked to suicide, in addition to reducing suicidality.
Psychoactive compound muscimol has been shown to treat stress and anxiety, ease muscular pain, and promote restorative sleep.
This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class research and drug development facility, and Awakn Life Sciences buys up ketamine clinics across the Nordics.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.